Notice of Intent to Sole-Source DNANexus Platform as a Service (PaaS) for cloud-based data analysis and management
Closed Special Notice Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 75N91024Q00079
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541519 Other Computer Related Services
- Place of performance
- Rockville, Maryland 20850, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) has issued a Special Notice for the sole-source procurement of a cloud-based Platform as a Service (PaaS) from DNANexus Inc. to support the NCI's data analysis and management requirements for the Confluence Project.
The purpose of this Special Notice is to inform the public of the NCI's intent to acquire the DNANexus PaaS solution on a sole-source basis, as it is the only commercially available platform that meets the computational, security, and regulatory requirements necessary to support the project's needs. The response deadline is April 12, 2024, and while this is not a request for competitive quotations, any interested parties, especially small businesses, that believe they can meet the government's requirements are invited to submit a capability statement, proposal, or quote for consideration. To be eligible for award, contractors must be registered and have valid certification through SAM.gov.
Notice text
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics plans to procure, on a sole source basis, cloud-based data analysis and management Platform as a Service (PaaS) from:
DNANexus Inc
1975 W El Camino Real
Suite 101
Mountain View, CA 94040
The response close date of the notice for this requirement is in accordance with FAR 5.203(b). This acquisition will be processed under FAR Part 12 – Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.501(a), and is exempt from the requirements of FAR Part 6.
DNAnexus is the sole provider of a commercially-available cloud PaaS solution that meets all the computational, security, and regulatory requirements necessary to support the NCI's requirements. DNAnexus is the only platform which holds a FedRAMP Moderate certification, can comply with GDPR regulations imposed by the European Union (EU) applicable to NCI’s European stakeholders, and can also meet the technical requirements for this effort.
DNAnexus is a unique platform which offers simplified, web-based access to complex computing-intensive applications; a simplified development environment for in-house pipelines, and simplified deployment and access to interactive HTML or R-shiny community-developed applications.
DNAnexus is the sole provider of the DNAnexus licenses and associated support services and does not work with resellers or third-party vendors.
This notice is not a request for competitive quotations. However, if any interested party, especially a small business, believes it can meet the Government’s needs, it may submit a capability statement, proposal, or quote for the Government to consider. The response and any other information furnished must be in writing and must contain sufficient details to allow NCI to determine if the party can perform the requirement. Responses to this notice shall be submitted via email to the Contracting Officer, Renee Jones-Chuang, at renee.jones-chuang@nih.gov no later than the date and time specified in this notice. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered for the purpose of determining whether to conduct a competitive procurement.The Government reserves the right to use the information provided by respondents for any purpose deemed necessary and legally appropriate. To receive an award, Contractors must be registered and have valid certification through SAM.GOV. Please reference the notice number, 75N91024Q00079, on all correspondence.
***Please reference attached Statement of Work for more details pertaining to the nature of the work to be performed.***
Files
| File | Type | Posted |
|---|---|---|
| NCI Statement of Work - Draft.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Notice of Award of Sole-Source Purchase Order for DNANexus Platform as a Service (PaaS) for cloud-based data analysis and management | Award Notice | |
| This notice | Special Notice |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| RNA sequencing and whole genome sequencing services | Office of Logisitics and Acquisition Operations | No set-aside | |
| 1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) | National Institute of Allergy and Infectious Diseases | No set-aside | |
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity